GENinCode specializes in cardiovascular disease risk. Cardiovascular disease is the leading cause of death and disability worldwide.
GENinCode products combine genetic and clinical data to risk assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease.
Our products help inform patients of their health risk enabling them to make behavioural or ‘lifestyle’ changes whilst providing doctors with greater genetic insight and clinical information to determine the most effective treatment pathway (precision medicine).
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. Our molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset.
With over 15 years research and development in cardiovascular health genomics GENinCode has amassed a deep knowledge and understanding of the interactions between a patient’s genetic profile, lifestyle and clinical risk factors.